logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Carboplatin CAS 41575-94-4

Carboplatin CAS 41575-94-4

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: CAS 41575-94-4

Payment & Shipping Terms

Minimum Order Quantity: negotiation

Price: negotiation

Packaging Details: bag;Drum

Delivery Time: 7-15 days

Payment Terms: T/T, D/A, L/C, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
41575-94-4
Appearance::
White Crystalline Powder
Molecular Formula::
C6H12N2O4Pt
Molecular Weight::
371.25
EINECS NO::
255-446-0
MDL NO::
MFCD00070464
CAS NO::
41575-94-4
Appearance::
White Crystalline Powder
Molecular Formula::
C6H12N2O4Pt
Molecular Weight::
371.25
EINECS NO::
255-446-0
MDL NO::
MFCD00070464
Carboplatin CAS 41575-94-4

Product Description:

Product Name: Carboplatin CAS 41575-94-4

 

Synonyms:

azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+);

cis-Diammine(1,1-cyclobutanedicarboxylato)platinum;

 

 

Chemical & Physical Properties:

Appearance: white crystalline powder

Assay: ≥ 99.0%

Melting point:228-230℃

Boiling Point: 366.4℃ at 760mmHg

Flash Point: 189.6℃

Water solubility: Sparingly soluble in water, very slightly soluble in aceton e and in ethanol (96 per cent). | Soluble in water.

 

Uses:

The range of action of carboplatin is generally similar to that of cisplatin. The main advantage of this new analogue is its difference in toxicity. Currently, carboplatin is used as a palliative treatment for recurrent ovarian cancer, including patients who have previously received cisplatin. Clinical studies have also shown that carboplatin can produce objective responses to head and neck tumors, small cell lung cancer, and testicular germ cell tumors.

 

At present, carboplatin is mainly used in the treatment of small cell lung cancer, ovarian cancer, testicular cancer, germ cell tumor, thyroid cancer, nasopharyngeal cancer, as well as cervical cancer, non small cell lung cancer, esophageal cancer, seminoma, bladder cancer cancer, mesothelioma, brain tumors in children and other head and neck cancers.

 

Patients who cannot tolerate cisplatin due to renal dysfunction, refractory vomiting, hearing loss, or neurotoxicity can use this product. It has no cross resistance with other chemotherapy drugs and can be used alone or in combination with other chemotherapy drugs. It can also be used in conjunction with surgery and radiotherapy to improve efficacy.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.